{"data":{"id":"us-wa/rcw-70.225.070","jurisdiction":"us-wa","citation":"RCW 70.225.070","heading":"Requirements for test sites in the prescription monitoring program.","body":"(1) Test sites that may receive access to data in the prescription monitoring program under RCW 70.225.040 must be:\n(a) Licensed by the department as a test site under chapter 70.42 RCW; and\n(b) Certified as a drug testing laboratory by the United States department of health and human services, substance abuse and mental health services administration.\n(2) Test sites may not:\n(a) Charge a fee for accessing the prescription monitoring program;\n(b) Store data accessed from the prescription drug monitoring program in any form, including, but not limited to, hard copies, electronic copies, or web/digital based copies of any kind. Such data may be used only to transmit to those entities listed in *RCW 70.255.040(3)(a).","path":["Title 70","Chapter 70.225"],"source_url":"https://app.leg.wa.gov/rcw/default.aspx?cite=70.225.070","current_through":"July 15, 2026","vintage":"","retrieved_at":"2026-09-06T03:54:48Z","sha256":"958c2af98cf3b8adf680ca7f9846f4a5f2c07cfdad4bc88dee258cb3bbb4fb13","source_id":"us-wa","stale":false,"prev":"us-wa/rcw-70.225.060","next":"us-wa/rcw-70.225.080"},"notice":"GroundRules: Original legal text. Not legal advice."}